Hearing on “Examining Medical Product Development in the Wake of the Ebola Epidemic,” Subcommittee on Health (November 19, 2014)

Documents

Memorandum from Ranking Member Waxman to Subcommittee on Health

Opening Statement of Ranking Member Waxman, as prepared for delivery.

Witnesses

Dr. Anthony Fauci
Director, National Institute of Allergy and Infectious Diseases
National Institutes of Health (NIH)
Testimony

Dr. Luciano Borio
Director, Office of Counterterrorism and Emerging Threats
U.S. Food and Drug Administration
Testimony

Rear Admiral Stephen Redd, MD
Senior Advisor for Ebola Response
Centers for Disease Control and Prevention (CDC)
Testimony

Dr. Robin Robinson
Director
BARDA
Testimony

Webcast

Key Documents: 

Memorandum from Ranking Member Henry A. Waxman, “Examining Medical Product Development in the Wake of the Ebola" (November 17, 2014).

Statement of Ranking Member Henry A. Waxman, Hearing on “Examining Medical Product Development in the Wake of the Ebola Epidemic,” Subcommittee on Health (November 19, 2014).

Testimony of Dr. Anthony Fauci, National Institutes of Health (NIH), Hearing on "Examining Medical Product Development in the Wake of the Ebola Epidemic", Subcommittee on Health (November 19, 2014).

Testimony of Dr. Luciana Borio, U.S. Food and Drug Administration (FDA), Hearing on “Examining Medical Product Development in the Wake of the Ebola Epidemic,” Subcommittee on Health (November 19, 2014).

Testimony of Dr. Stephen Redd, Centers for Disease Control and Prevention (CDC), Hearing on “Examining Medical Product Development in the Wake of the Ebola Epidemic,” Subcommittee on Health (November 19, 2014).

Testimony of Dr. Robin Robinson, Biomedical Advanced Research and Development Authority's Response (BARDA), Hearing on “Examining Medical Product Development in the Wake of the Ebola Epidemic,” Subcommittee on Health (November 19, 2014).